Concepedia

Elsa Krall

EK

Statistics

Publications

5

Citations

1.1K

H-Index

5

Active since

2014

Affiliations

Dana-Farber Cancer Institute(Current)

Broad Institute

Harvard University

Brigham and Women's Hospital

Q Therapeutics (United States)

Elsa Krall is an author at Dana-Farber Cancer Institute specializing in cell biology, medicine, and cell signaling.

Top concepts

Publications per year

2014–2024

5

Publications

5

KRAS and YAP1 Converge to Regulate EMT and Tumor Survival

Diane D. Shao, Wen Xue, Elsa Krall et al. · Cell · 2014 · 744 citations

, , +7

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

Elsa Krall, Belinda Wang, Diana M. Muñoz et al. · eLife · 2017 · 155 citations · Full text

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition

Belinda Wang, Elsa Krall, Andrew J. Aguirre et al. · Cell Reports · 2017 · 119 citations · Full text

, , +6

STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer

Joseph D. Fleming, Paul G. Giresi, Marianne Lindahl-Allen et al. · Epigenetics & Chromatin · 2015 · 41 citations · Full text

The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors

Louise Cadzow, Jehrod Brenneman, Erica R. Tobin et al. · Cancer Research · 2024 · 34 citations · Full text

1–5 of 5